Your browser doesn't support javascript.
loading
A cellular model reflecting the phenotypic heterogeneity of mutant HRAS driven squamous cell carcinoma.
Cantariño, Neus; Fernández-Figueras, M Teresa; Valero, Vanesa; Musulén, Eva; Malinverni, Roberto; Granada, Isabel; Goldie, Stephen J; Martín-Caballero, Juan; Douet, Julien; Forcales, Sonia-Vanina; Buschbeck, Marcus.
Afiliação
  • Cantariño N; Institute of Predictive and Personalized Medicine of Cancer, Campus Can Ruti, Badalona, Spain.
  • Fernández-Figueras MT; Department Of Pathology, Hospital Universitari Germans Trias I Pujol, Campus Can Ruti, Badalona, Spain.
  • Valero V; Institute of Predictive and Personalized Medicine of Cancer, Campus Can Ruti, Badalona, Spain.
  • Musulén E; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO - Germans Trias I Pujol, (IJC), Campus Can Ruti, Badalona, Spain.
  • Malinverni R; Department Of Pathology, Hospital Universitari Germans Trias I Pujol, Campus Can Ruti, Badalona, Spain.
  • Granada I; Institute of Predictive and Personalized Medicine of Cancer, Campus Can Ruti, Badalona, Spain.
  • Goldie SJ; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO - Germans Trias I Pujol, (IJC), Campus Can Ruti, Badalona, Spain.
  • Martín-Caballero J; Josep Carreras Leukaemia Research Institute (IJC), Campus ICO - Germans Trias I Pujol, (IJC), Campus Can Ruti, Badalona, Spain.
  • Douet J; Department of Hematology, Instituto Catalán De Oncología (ICO) - Hospital Universitari Germans Trias I Pujol, Universitat Autònoma De Barcelona, Campus Can Ruti, Badalona, Spain.
  • Forcales SV; Li KaShing Centre, Cancer Research UK Cambridge Research Institute, Robinson Way, Cambridge, CB2 0RE, United Kingdom.
  • Buschbeck M; Animal Facility, PRBB, Barcelona, 08003, Spain.
Int J Cancer ; 139(5): 1106-16, 2016 09 01.
Article em En | MEDLINE | ID: mdl-27074337
ABSTRACT
Squamous cell carcinomas have a range of histopathological manifestations. The parameters that determine this clinically observed heterogeneity are not fully understood. Here, we report the generation of a cell culture model that reflects part of this heterogeneity. We have used the catalytic subunit of human telomerase hTERT and large T to immortalize primary UV-unexposed keratinocytes. Then, mutant HRAS G12V has been introduced to transform these immortal keratinocytes. When injected into immunosuppressed mice, transformed cells grew as xenografts with distinct histopathological characteristics. We observed three major tissue architectures solid, sarcomatoid and cystic growth types, which were primarily composed of pleomorphic and basaloid cells but in some cases displayed focal apocrine differentiation. We demonstrate that the cells generated represent different stages of skin cancerogenesis and as such can be used to identify novel tumor-promoting alterations such as the overexpression of the PADI2 oncogene in solid-type SCC. Importantly, the cultured cells maintain the characteristics from the xenograft they were derived from while being amenable to manipulation and analysis. The availability of cell lines representing different clinical manifestations opens a new tool to study the stochastic and deterministic factors that cause case-to-case heterogeneity despite departing from the same set of oncogenes and the same genetic background.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenótipo / Carcinoma de Células Escamosas / Proteínas Proto-Oncogênicas p21(ras) / Mutação Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Int J Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenótipo / Carcinoma de Células Escamosas / Proteínas Proto-Oncogênicas p21(ras) / Mutação Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Int J Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha